Division of Research and Development, Pharmin USA, LLC, San Jose, CA, USA.
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Int J Low Extrem Wounds. 2021 Dec;20(4):337-346. doi: 10.1177/1534734620915327. Epub 2020 Apr 19.
The present study aimed to evaluate the effect of liposomal arthrocen 2% (ROCEN) on the healing of burn wound and pain alleviation of thermal stimuli in a rat model of the second-degree burn. The results showed that ROCEN formulation significantly improved the main parameters of burn wound healing in a short period of time (7 days). The percentage of wound surface was also reduced significantly compared with the control group following once daily application of ROCEN for 14 days. The level of TGF (transforming growth factor)-β1 cytokine was also elevated significantly in the burn tissue treated with ROCEN almost the same as zinc oxide cream. Also, ROCEN showed a significant analgesic effect evaluated by 2 models of acute thermal pain, tail-flick and hotplate tests, which suggested that the formulation may act as a pain reliever in burn injuries. In conclusion, the application of the topical formulation of ROCEN may have benefits in the acceleration of the wound healing process and alleviation of the pain due to burn injuries.
本研究旨在评估 2%脂质体关节腔注射剂(ROCEN)对二度烧伤大鼠模型的烧伤创面愈合和热刺激缓解疼痛的影响。结果表明,ROCEN 配方在短时间内(7 天)显著改善了烧伤创面愈合的主要参数。与对照组相比,在每日一次应用 ROCEN 治疗 14 天后,创面面积百分比也显著降低。在接受 ROCEN 治疗的烧伤组织中,TGF-β1 细胞因子水平也显著升高,几乎与氧化锌乳膏相同。此外,ROCEN 通过两种急性热痛模型(尾巴闪烁和热板试验)显示出显著的镇痛效果,这表明该配方可能在烧伤损伤中作为一种止痛药。总之,ROCEN 的局部应用可能有利于加速创面愈合过程并缓解烧伤引起的疼痛。